<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28">
 <label>28</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hua</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Stein</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hua</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Role of Toll-like receptor mediated signaling in traumatic brain injury</article-title>
  <source>
   <italic toggle="yes">Neuropharmacology</italic>
  </source>
  <year>2019</year>
  <volume>145</volume>
  <issue>Part B</issue>
  <fpage>259</fpage>
  <lpage>267</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.07.022</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85050905914</pub-id>
  <?supplied-pmid 30075158?>
  <pub-id pub-id-type="pmid">30075158</pub-id>
 </element-citation>
</ref>
